Barinthus Biotherapeutics plc.
Clinical-stage biopharma developing immunotherapies that guide T cells to control disease.
BRNS | US
Overview
Corporate Details
- ISIN(s):
- US91864C1071
- LEI:
- Country:
- United States of America
- Address:
- 20400 CENTURY BLVD, 20874 GERMANTOWN
- Website:
- https://www.barinthusbio.com/
- Sector:
- Manufacturing
Description
Barinthus Biotherapeutics plc is a clinical-stage biopharmaceutical company that develops novel immunotherapies designed to guide T cells to control disease. The company is advancing a new generation of antigen-specific immunotherapeutics for treating autoimmunity, chronic infectious diseases, and cancer. Its therapeutic approach focuses on creating candidates that can overcome these conditions by modulating the body's T cell response. The development pipeline includes programs targeting various indications, with a strategic focus on immunology and inflammatory diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Barinthus Biotherapeutics plc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Barinthus Biotherapeutics plc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Barinthus Biotherapeutics plc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
